Tissue Diagnostics Market | Global Forecast 2022 | Key Players Agilent Technologies (US), Merck (Germany), and Sakura Finetek Japan (Japan)

The global tissue diagnostics market is dominated by North America, followed by Europe. North America will continue to dominate the global market during the forecast period. However, Asia is expected to witness the highest CAGR during the forecast period with growth centered at Japan, China, and India. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region.

The factors such as the high degree of consolidation, the high cost of instruments, and complex regulatory framework for the approval of new products may restrain market growth to a certain extent.

Major industry players launched innovative products to maintain and improve their position in the tissue diagnostics market. Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), Merck (Germany), and Sakura Finetek Japan (Japan) have been identified as the key players in this market. These companies have a broad product portfolio with comprehensive features and have also launched innovative products. These leaders have products for all end users in this market, a strong geographical presence, and focus on continuous product innovations.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Target Audience for this Report:

  • Manufacturers and vendors of tissue diagnostics equipment
  • Research associations related to tissue diagnostics
  • Pathologists and pathology laboratories
  • Various research and consulting firms
  • Distributors of tissue diagnostics equipment
  • Contract research manufacturers of tissue diagnostics equipment
  • Government bodies
  • Tissue diagnostics database and software providers
  • Venture capitalists

The global tissue diagnostics market is segmented by product, technology, disease, end user, and regions. By product, the market is segmented into instruments and consumables. The consumables segment is estimated to account for the largest market share of the global market in 2017. Factors driving the growth of this segment include the widespread use of consumables and advances in technology to develop novel consumables.

By technology, the market is classified into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. The immunohistochemistry segment is estimated to account for the largest share of the global tissue diagnostics market during the next five years. Growth in the IVD (in vitro diagnostics) market and the large number of products based on this technology are driving the growth of this market.